PerspectiveOsteoporosis

β-Arrestin–Biased Parathyroid Hormone Ligands: A New Approach to the Development of Agents that Stimulate Bone Formation

See allHide authors and affiliations

Science Translational Medicine  07 Oct 2009:
Vol. 1, Issue 1, pp. 1ps1
DOI: 10.1126/scitranslmed.3000268

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine